Issue Information

2024-9-1

Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis

2024-9-1

Longitudinal Epidemiology of Mucormycosis Within the Veterans Health Administration: A Retrospective Cohort Study Over a 20‐Year Period

2024-9-1

High Prevalence of Azole‐Resistant <i>Aspergillus fumigatus</i> Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?

2024-9-1

The Emergence of New <i>Sporothrix brasiliensis</i> Genotypes in Current Epidemic of Sporotrichosis in Southeastern Brazil

2024-9-1

Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)

2024-9-1

A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: <scp>CHARTER</scp>‐<scp>IFI</scp> study

2024-8-1

Early <i>Candida</i> colonisation impact on patients and healthcare professionals in an intensive care unit

2024-8-1

Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021

2024-8-1

Incidence and risk factors for coronavirus disease 2019‐associated pulmonary aspergillosis using administrative claims data

2024-8-1

The <i>Aspergillus</i> galactomannan Ag <scp>VIRCLIA</scp>® Monotest and the sõna <i>Aspergillus</i> galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis

2024-8-1

Performance of the <scp>IMMY</scp>® sona <i>Aspergillus</i> lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with <scp>COVID</scp>‐19‐associated pulmonary aspergillosis: Cross‐sectional and systematic review of literature

2024-8-1

Population prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in COPD subjects in North India

2024-8-1

<scp>Revision</scp> of antifungal strategies <scp>definitions</scp> for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (<scp>REDEFI</scp>‐<scp>SEIFEM</scp>)

2024-8-1

Epidemiological changes of invasive fungal disease in children with cancer: Prospective study of the National Child Program of Antineoplastic Drugs network, Chile

2024-8-1

<i>Inopinatus corneliae</i> sp. nov. gen. nov. isolated from human skin: A newly discovered keratinophilic hyphomycete, order Onygenales

2024-8-1

Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures

2024-8-1

Multi‐state evaluation of <i>Candida</i> infections in burn patients

2024-8-1

Prolonged treatment of dermatophytosis caused by <i>Trichophyton indotinea</i> with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene

2024-7-31

Genotypic and phenotypic characterisation of a nosocomial outbreak of <i>Candida auris</i> in Spain during 5 years

2024-7-31

Factors associated with pityriasis versicolor in a large national database

2024-7-30

Issue Information

2024-7-29

Next generation mycological diagnosis: Artificial intelligence‐based classifier of the presence of <i>Malassezia</i> yeasts in tape strip samples

2024-7-29

Clinical and microbiological characteristics of a hospital outbreak of <i>Candida auris</i> in a referral hospital in Lima, Peru

2024-7-1

Potential emergence of terbinafine resistance by squalene epoxidase gene mutations: An 18‐month cohort study of onychomycosis patients in the United States

2024-7-1

Azole resistance in <i>Aspergillus flavus</i> and associated fitness cost

2024-7-1

Cutaneous fusarium disease and leukaemias: A systematic review

2024-7-1

Propensity of <i>Candida</i> spp. prosthetic joint infection clinical isolates to form aggregates in synovial fluid and the clinical ramifications

2024-7-1

Global burden of fungal skin diseases: An update from the Global Burden of Diseases Study 2019

2024-7-1

Association between the hypokalaemia index based on area over the serum potassium concentration curve and occurrence of acute kidney injury in patients administered liposomal amphotericin B

2024-7-1

The role of surgery for invasive pulmonary aspergillosis in paediatric hemato‐oncology patients—Can we better define it?

2024-7-1

Association between neuroimaging and clinical outcomes in individuals with central nervous system cryptococcosis

2024-7-1

Invasive fungal infections in wars, following explosives and natural disasters: A narrative review

2024-7-1

Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?

2024-7-1

Mechanism of azole resistance in <i>Candida vulturna</i>, an emerging multidrug resistant pathogen related with <i>Candida haeumulonii</i> and <i>Candida auris</i>

2024-7-1

Impact of <scp>COVID</scp>‐19 on paracoccidioidomycosis. Which was the most influential: The pandemic or the virus?

2024-6-30

Exploring treatment and antifungal resistance in an outbreak of tinea caused by <i>Microsporum audouinii</i>

2024-6-28

Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county

2024-6-27

Issue Information

2024-6-27

Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre study

2024-6-1

Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand

2024-6-1

Cover Image

2024-6-1

Multicenter <i>Candida auris</i> outbreak caused by azole‐susceptible clade <scp>IV</scp> in Pernambuco, Brazil

2024-6-1

Performance of the clarus <i>Aspergillus</i> galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum

2024-6-1

<i>Candida albicans</i> skin infection in diabetic patients: An updated review of pathogenesis and management

2024-6-1

A survey of 701 cases of tinea faciei in Hangzhou, southeastern China, from 2018 to 2023

2024-6-1